Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$59,158
+$24,758 QoQ
Shares Held
4,448
+20.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#119
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,682,435 across 292 Biotechnology names. FDMT ranks #177 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in FDMT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,158 | 4,448 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $34,400 | 3,695 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $27,712 | 3,695 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $32,109 | 3,695 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,708 | 3,695 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $40,742 | 12,614 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $190,938 | 34,280 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $349,961 | 32,374 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $622,100 | 29,638 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $802,457 | 25,187 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $497,361 | 24,549 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $310,751 | 24,411 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $436,860 | 24,176 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $121,498 | 7,068 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $63,209 | 2,846 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $75,471 | 9,387 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $65,520 | 9,387 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $124,588 | 8,240 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $180,785 | 8,240 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $148,469 | 5,505 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,601 | 814 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $34,356 | 792 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||